Jan 25, 2016 08:38 AM EST
As for the prevention against the Ebola epidemic in the future, a $5 million deal on Ebola vaccine has been signed by Gavi.
In regards to the deal, Merck, the pharmaceutical company producing the vaccine, has to keep 300,000 vaccines prepared for any emergency situation or to be used for other medical trials. The vaccine is planned to be registered for license by the end of 2017, according to BBC. This action is expected to ease Gavi organizing the Ebola vaccine stockpile for global use.
The recent Ebola outbreak in West Africa is the worst in the history. The disease has caused 11,000 deaths, forcing for a faster work on getting vaccines from a decade study into not more han a year.
The vaccine from Merck, called VSV-EBOV, has been gone through tests, and the results obtained from the West Africa studies show that the vaccine may provide 100% protection. However, it is still in the process of collecting more data.
The VSV-EBOV vaccine combines a part from the Ebola virus with a different kind of virus, which is safer, to train the body immunity to fight against Ebola.
Gavi is an alliance, which is committed to save lives through vaccination. The chief executive of Gavi, Dr Seth Berkley said, "The suffering caused by the Ebola crisis was a wake-up call to many in the global health community. New threats require smart solutions, and our innovative financing agreement with Merck will ensure that we are ahead of the curve for future Ebola outbreaks."
The deal will also assist Merck to obtain license and go through prequalification from the World Health Organization. As mentioned in Ocean Side Post, Merck has proposed an application through the procedure from the WHO's Emergency Use Assessment and Listing (EUAL). If there is an approval, the vaccine is allowed to be used before it is licensed with the authority from the World Health Organization in crisis circumstances.
A public-health scientist at the University of Minnesota's Center for Infectious Disease Research and Policy in Minneapolis, Michael Osterholm said, "We are in the most tenuous situation with regard to Ebola vaccines that we've seen since we started all of this."
According to Nature, public-health scientists are worried with the outbreak in West Africa, "there is danger that the work of stockpiling, licensing and planning to administer Ebola vaccines will be set aside in favour of more pressing - and profitable - pursuits."
In the past year, Merck, Johnson&Johnson and GlaxoSmithKline have produced 2 million doses of candidate vaccines. These vaccines have been given to more than 20,000 people and thousands more shortly. The supply is said to be sufficient to protect people from the future Ebola epidemic.
By examining key aspects such as security measures, customer service, user experience, transaction convenience, and potential for innovation, we strive to offer an in-depth perspective on this reputable trading platform.
And the world of NFTs expands far beyond art and collectibles. A new era of tokenized digital assets is being created using the blockchain. Here are seven unique NFT use cases that the interested investor should know.
However, there are some simple steps that anyone can take which will help to improve their performance when it comes to trading foreign exchange markets. Here are ten small things that can make a big difference in your FX trading success.
o prevent significant losses, risk management expertise is essential. His adage, "Rule No. 1: Never lose money," has become a stock market classic. Never forget Rule No. 1; this is Rule No. 2. This practice is followed by even the most successful investor, Warren Buffett, who advises others to follow suit.
One of the significant advancements is shifting the payment operations for remote workers. If the compliances are not met, it may lead to severe legal complications. The owner and organization may be held labially separately. The remote working lifestyle continuously grows and is a testament to becoming an endless working mode. Today we discuss components for payroll for remote workers
BRG International Founder Matias Alem had recognized this fact for a few years. So he remodeled his real estate brokerage into something completely new to solve the problem for his jet-setting international client base.
Ryan Early, hailed as 'Farmer Ryan' among sustainable agriculture experts, is a busy man. He has a laundry list of companies to his name, including Blue-Green Ventures, the company behind the revolutionary product, Blue MagicTM, a non-toxic and eco-sustainable pest preventative product using his patented BiomeMax TM Pheromonal Replication Technology.
Investor, financier, and expert in both cryptocurrencies and blockchain technology, Joy Mbanugo is the go-to in the sector. She has vast experience and knowledge across tax services, auditing, business operations, financial analysis, capital markets, and other specializations.
When Nick Collins was just 14 years old, he started his first business, which included around-the-clock phone calls and numerous questions from his parents. In fact, he began building his stout portfolio in the seventh grade by doing web design, incorporating creative content with brand strategies and plugging in a then-fledgling tech Flash.
Barry Gabster is the founder of InitiateU and is a leading proponent of the marketing mailer revolution, having already taken his company to 10x growth in 2021, alone. In fact, the exponential growth has seen the company rise from $800K-$8.5M just on word-of-mouth referrals.